Pharos’ AI-Designed Leukemia Drug Earns Orphan Designation in Europe
Pharos iBio, a South Korea-based biotech specializing in AI-driven drug discovery, announced that its lead investigational asset PHI-101,…
Orphan Drug
2 개의 기사가 있습니다.
Onconic’s ‘Nesuparib’ Secures FDA Orphan Drug Status
Onconic Therapeutics (hereinafter referred to as "Onconic"), a subsidiary of Jeil Pharmaceutical specializing in new drug development, announced…